2-ethoxy-6-ethylnapthalene | 1999-63-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-ethoxy-6-ethylnapthalene
• 英文别名: 2-Ethoxy-6-ethylnaphthalene
• CAS: 1999-63-9
• 化学式: C₁₄H₁₆O
• 分子量: 200.28
• InChiKey: ZDXLEZVFNMMPPS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-ethoxy-6-ethylnapthalene 在 氢气 、 四甲基胍 作用下， 以 甲苯 为溶剂， 100.0 ℃ 、5.07 MPa 条件下， 反应 48.0h， 以65%的产率得到(-)-2-ethoxy-6-ethyl-1,2,3,4-tetrahydronaphthalene
  参考文献：
  名称：

  萘的催化不对称加氢

  摘要：

  消失的芳香性：手性钌络合物催化2,6或2,7-二取代的萘的氢化反应，得到手性四氢化萘的ee高达92％。手性催化剂适用于6-取代的2-烷氧基萘的区域和对映选择性还原，并优先氢化烷氧基取代的芳烃环。

  DOI：

  10.1002/anie.201201153
• 作为产物：
  描述：

  溴乙烷 、 2-溴-6-乙氧基萘 在 magnesium 、 1,3-bis[(diphenylphosphino)propane]dichloronickel(II) 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 以70%的产率得到2-ethoxy-6-ethylnapthalene
  参考文献：
  名称：

  萘的催化不对称加氢

  摘要：

  消失的芳香性：手性钌络合物催化2,6或2,7-二取代的萘的氢化反应，得到手性四氢化萘的ee高达92％。手性催化剂适用于6-取代的2-烷氧基萘的区域和对映选择性还原，并优先氢化烷氧基取代的芳烃环。

  DOI：

  10.1002/anie.201201153

文献信息

• Kinase antagonists
  申请人：Knight A. Zachary

  公开号：US20070293516A1

  公开（公告）日：2007-12-20

  The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tryosine kinase, PI3Kinase and mTOR, or PI3Kinase, mTOR and tryosine kinase.

  本发明提供了一种新型化合物，它们是 PI3 激酶、PI3 激酶和酪氨酸激酶、PI3 激酶和 mTOR，或者 PI3 激酶、mTOR 和酪氨酸激酶的拮抗剂。
• METHODS AND COMPOSITIONS FOR TREATMENT OF OPHTHALMIC CONDITIONS
  申请人：Wilson Troy Edward

  公开号：US20110269779A1

  公开（公告）日：2011-11-03

  The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating signal transduction by certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PB kinase in an ocular tissue. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications.

  本发明提供了能够调节特定蛋白激酶（如mTor、酪氨酸激酶和/或脂质激酶如PB激酶）在眼组织中的信号传导的化学实体或化合物以及其制药组合物。本发明还提供了利用这些组合物调节这些激酶中的一个或多个的活性的方法，特别是用于治疗应用。
• KINASE ANTAGONISTS
  申请人：KNIGHT ZACHARY A.

  公开号：US20100009963A1

  公开（公告）日：2010-01-14

  The present invention provides novel compounds that are antagonists of PI3 kinase, PI3 kinase and tyrosine kinase, PI3 kinase and mTOR, or PI33 kinase, mTOR and tyrosine kinase.

  本发明提供了一些新型化合物，它们是PI3激酶、PI3激酶和酪氨酸激酶、PI3激酶和mTOR、或PI3激酶、mTOR和酪氨酸激酶的拮抗剂。
• LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME
  申请人：Suwa Shunichi

  公开号：US20110157531A1

  公开（公告）日：2011-06-30

  A method of manufacturing a liquid crystal display device with which response characteristics are able to be easily improved without using major equipment is provided. The method of manufacturing a liquid crystal display device includes steps of forming a first alignment film 22 including a polymer compound having a crosslinkable functional group as a side chain on one substrate of a pair of substrates 20 and 30 ; forming a second alignment film 32 on the other substrate of the pair of substrates 20 and 30 ; arranging the pair of substrates 20 and 30 so that the first alignment film 22 and the second alignment film 32 are opposed to each other, and sealing a liquid crystal layer 40 containing a liquid crystal molecule 41 having negative dielectric constant anisotropy between the first alignment film 22 and the second alignment film 32 ; and bridging the polymer compound to give pretilt to the liquid crystal molecule 41 after sealing the liquid crystal layer 40.
• LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME
  申请人：Suwa Shunichi

  公开号：US20130010244A1

  公开（公告）日：2013-01-10

  Disclosed herein is a liquid crystal display having a liquid crystal display element, the liquid crystal display element including: a pair of alignment films provided on mutually facing sides of a pair of substrates; and a liquid crystal layer which is provided between the pair of alignment films and contains a liquid crystal molecule having a negative dielectric anisotropy, wherein at least one of the pair of alignment films contains a cross-linked compound obtained by cross-linking a polymer compound having a cross-linkable functional group as a side chain, the liquid crystal layer further contains a molecule which has a ring structure and a spacer linking the ring structure, and the liquid crystal molecule is given a pre-tilt by the cross-linked compound.